Format

Send to

Choose Destination
PLoS One. 2014 Apr 1;9(4):e92615. doi: 10.1371/journal.pone.0092615. eCollection 2014.

Attendance at cervical cancer screening and use of diagnostic and therapeutic procedures on the uterine cervix assessed from individual health insurance data (Belgium, 2002-2006).

Author information

1
Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium.
2
Intermutualistic Agency (IMA/AIM), Brussels, Belgium.
3
Department of Gynaecology and Obstetrics, Ghent University, Ghent, Belgium; Director, Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
4
Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium; Laboratory of Cell Biology and Histology, University of Antwerp, Antwerp, Belgium.

Abstract

OBJECTIVE:

To assess the coverage for cervical cancer screening as well as the use of cervical cytology, colposcopy and other diagnostic and therapeutic interventions on the uterine cervix in Belgium, using individual health insurance data.

METHODS:

The Intermutualistic Agency compiled a database containing 14 million records from reimbursement claims for Pap smears, colposcopies, cervical biopsies and surgery, performed between 2002 and 2006. Cervical cancer screening coverage was defined as the proportion of women aged 25-64 that had a Pap smear within the last 3 years.

RESULTS:

Cervical cancer screening coverage was 61% at national level, for the target population of women between 25 and 64 years old, in the period 2004-2006. Differences between the 3 regions were small, but varied more substantially between provinces. Coverage was 70% for 25-34 year old women, 67% for those aged 35-39 years, and decreased to 44% in the age group of 60-64 years. The median screening interval was 13 months. The screening coverage varied substantially by social category: 40% and 64%, in women categorised as beneficiary or not-beneficiary of increased reimbursement from social insurance, respectively. In the 3-year period 2004-2006, 3.2 million screen tests were done in the target group consisting of 2.8 million women. However, only 1.7 million women got one or more smears and 1.1 million women had no smears, corresponding to an average of 1.88 smears per woman in three years of time. Colposcopy was excessively used (number of Pap smears over colposcopies = 3.2). The proportion of women with a history of conisation or hysterectomy, before the age of 65, was 7% and 19%, respectively.

CONCLUSION:

The screening coverage increased slightly from 59% in 2000 to 61% in 2006. The screening intensity remained at a high level, and the number of cytological examinations was theoretically sufficient to cover more than the whole target population.

PMID:
24690620
PMCID:
PMC3972167
DOI:
10.1371/journal.pone.0092615
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center